Primary Sjogren's syndrome: Extraglandular manifestations and hydroxychloroquine therapy.
Clin Rheumatol. 2017 Nov;36(11):2455-2460. doi: 10.1007/s10067-017-3822-3. Epub 2017 Sep 14.
Clin Rheumatol. 2017.
PMID: 28913747
The use of hydroxychloroquine (HCQ) in Primary Sjogren's Syndrome (pSS) has been assessed in different studies over the last years, with conflicting results regarding its efficacy in sicca syndrome and extraglandular manifestations (EGM). ...Sub …
The use of hydroxychloroquine (HCQ) in Primary Sjogren's Syndrome (pSS) has been assessed in different studies o …